Literature DB >> 23021047

Melanoma staging: where are we now?

Adriano Piris1, Alice Coelho Lobo, Lyn M Duncan.   

Abstract

The seventh version of the American Joint Committee on Cancer (AJCC) Melanoma Staging guidelines, published in 2009, has significant revisions compared with the previous version. The current schema was based on the largest melanoma patient cohort analyzed to date and is the result of a multivariate analysis of 30,946 patients with stages I, II, and III melanoma and 7972 patients with stage IV melanoma. This article summarizes the findings and the new definitions included in the 2009 AJCC Melanoma Staging and Classification. The TNM categories and the stage groupings are defined. Changes in the melanoma staging system are summarized.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23021047     DOI: 10.1016/j.det.2012.06.001

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

Review 1.  Emerging Biomarkers in Cutaneous Melanoma.

Authors:  Anna Eisenstein; Estela Chen Gonzalez; Rekha Raghunathan; Xixi Xu; Muzhou Wu; Emily O McLean; Jean McGee; Byungwoo Ryu; Rhoda M Alani
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

2.  Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.

Authors:  Mara Giavina-Bianchi; Pedro Giavina-Bianchi; Mirian Nacagami Sotto; Alona Muzikansky; Jorge Kalil; Cyro Festa-Neto; Lyn M Duncan
Journal:  J Immunol Res       Date:  2015-04-14       Impact factor: 4.818

3.  Host kinin B1 receptor plays a protective role against melanoma progression.

Authors:  Andrea G Maria; Patrícia Dillenburg-Pilla; Rosana I Reis; Elaine M Floriano; Cristiane Tefé-Silva; Simone G Ramos; João B Pesquero; Clara Nahmias; Claudio M Costa-Neto
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

4.  A six-long non-coding RNA signature predicts prognosis in melanoma patients.

Authors:  Shuocheng Yang; Jianguo Xu; Xuan Zeng
Journal:  Int J Oncol       Date:  2018-02-07       Impact factor: 5.650

5.  Optimizing Detection of Lymphatic Invasion in Primary Cutaneous Melanoma With the Use of D2-40 and a Paired Melanocytic Marker.

Authors:  Richard J Straker; Laura A Taylor; Madalyn G Neuwirth; Andrew J Sinnamon; Adrienne B Shannon; James Abbott; John T Miura; Emily Y Chu; Xiaowei Xu; Giorgos C Karakousis
Journal:  Am J Dermatopathol       Date:  2022-01-01       Impact factor: 1.319

6.  Inclusion of populations at risk of advanced melanoma in an opportunistic targeted screening project involving general practitioners.

Authors:  Cédric Rat; Gaelle Quereux; Charlotte Grimault; Jérémy Fernandez; Mickael Poiraud; Aurélie Gaultier; Anicet Chaslerie; Jacques Pivette; Amir Khammari; Brigitte Dreno; Jean-Michel Nguyen
Journal:  Scand J Prim Health Care       Date:  2016-07-28       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.